Author: ODEWUMI, CAROLINE; LATINWO, LEKAN M.; SINCLAIR, ANDRE; BADISA, VEERA L.D.; ABDULLAH, AHKINYALA; BADISA, RAMESH B.
Title: Effect of cadmium on the expression levels of interleukin-1a and interleukin-10 cytokines in human lung cells Document date: 2015_9_10
ID: roy4420g_18
Snippet: metallothionein compared with their corresponding normal cells (28) . This may be one of the contributing factors for the higher sensitivity of cancer cells to cadmium toxicity, however, further investigation is required to prove this hypothesis. Normal lung cells and the lung cancer cells revealed high expression levels of the IL-1α and IL-10 cytokines following treatment with CdCl 2 (Figs. 1 and 2) . In a previous study (29) , a significant in.....
Document: metallothionein compared with their corresponding normal cells (28) . This may be one of the contributing factors for the higher sensitivity of cancer cells to cadmium toxicity, however, further investigation is required to prove this hypothesis. Normal lung cells and the lung cancer cells revealed high expression levels of the IL-1α and IL-10 cytokines following treatment with CdCl 2 (Figs. 1 and 2) . In a previous study (29) , a significant increase in IL-1α and IL-10 cytokines was observed in the tested cells, when human-derived bronchial epithelium was exposed to tobacco smoke components. Furthermore, other previous studies have revealed that cells release pro-inflammatory cytokines during inflammation, to activate the cytokine network and the secretion of anti-inflammatory cytokines (30, 31) . The higher expression of cytokines, which lead to inflammation, may be responsible for the later cytotoxic effects in the cells, which lead to a decrease in viability, as observed in the present study (Fig. 1 ). This is supported by a previous study (32) demonstrating that high levels of pro-inflammatory cytokines due to cadmium exposure cause pathological conditions in a biological system.
Search related documents:
Co phrase search for related documents- high level and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- high level and lung cancer cell: 1, 2
- high level and lung cell: 1, 2, 3, 4, 5, 6, 7, 8
- lung cancer and normal cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- lung cancer and normal lung cell: 1, 2, 3, 4, 5, 6, 7, 8
- lung cancer and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57
- lung cancer and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- lung cancer and pro inflammatory cytokine: 1, 2
- lung cancer and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- lung cancer and test cell: 1, 2
- present study and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77
- present study and pro inflammatory cytokine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- present study and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- present study and test cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- present study and viability decrease: 1, 2, 3, 4, 5
- previous study and pro inflammatory cytokine: 1, 2, 3, 4, 5
- previous study and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- previous study and test cell: 1
- previous study and viability decrease: 1
Co phrase search for related documents, hyperlinks ordered by date